These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 12435286)
1. Simultaneous occurrence of Hodgkin's lymphoma and eosinophilic granuloma: a potential pitfall in positron emission tomography imaging. Naumann R; Beuthien-Baumann B; Fischer R; Kittner T; Bredow J; Kropp J; Ockert D; Ehninger G Clin Lymphoma; 2002 Sep; 3(2):121-4. PubMed ID: 12435286 [TBL] [Abstract][Full Text] [Related]
2. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma. Qiu L; Chen Y; Wu J Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease. Spaepen K; Mortelmans L Q J Nucl Med; 2001 Sep; 45(3):269-73. PubMed ID: 11788819 [TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET in malignant lymphoma: significance of positive findings. Castellucci P; Zinzani P; Pourdehnad M; Alinari L; Nanni C; Farsad M; Battista G; Tani M; Stefoni V; Canini R; Monetti N; Rubello D; Alavi A; Franchi R; Fanti S Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):749-56. PubMed ID: 15785956 [TBL] [Abstract][Full Text] [Related]
5. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma. Shen YY; Kao A; Yen RF Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600 [TBL] [Abstract][Full Text] [Related]
6. Sarcoidosis and sarcoid-like reaction following Hodgkin's disease. Report of two cases. de Hemricourt E; De Boeck K; Hilte F; Abib A; Kockx M; Vandevivere J; De Bock R Mol Imaging Biol; 2003; 5(1):15-9. PubMed ID: 14499156 [TBL] [Abstract][Full Text] [Related]
7. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. Wirth A; Seymour JF; Hicks RJ; Ware R; Fisher R; Prince M; MacManus MP; Ryan G; Januszewicz H; Wolf M Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? Spaepen K; Stroobants S; Dupont P; Van Steenweghen S; Thomas J; Vandenberghe P; Vanuytsel L; Bormans G; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G J Clin Oncol; 2001 Jan; 19(2):414-9. PubMed ID: 11208833 [TBL] [Abstract][Full Text] [Related]
9. Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma. Alkhawtani RHM; Noordzij W; Glaudemans AWJM; van Rijn RS; van der Galiƫn HT; Balink H; Nijland M; Adams HJA; Huls G; van Meerten T; Kwee TC Nucl Med Commun; 2018 Jun; 39(6):572-578. PubMed ID: 29672465 [TBL] [Abstract][Full Text] [Related]
10. Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma. Torizuka T; Nakamura F; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Kobayashi M; Ouchi Y Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):22-8. PubMed ID: 14574514 [TBL] [Abstract][Full Text] [Related]
11. Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography. Hwang K; Park CH; Kim HC; Kim H; Yoon S; Pai M; Kim S Clin Nucl Med; 2000 Oct; 25(10):789-95. PubMed ID: 11043718 [TBL] [Abstract][Full Text] [Related]
12. Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow. Elstrom RL; Tsai DE; Vergilio JA; Downs LH; Alavi A; Schuster SJ Clin Lymphoma; 2004 Jun; 5(1):62-4. PubMed ID: 15245610 [TBL] [Abstract][Full Text] [Related]
13. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420 [TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma. Cremerius U; Fabry U; Neuerburg J; Zimny M; Osieka R; Buell U Nucl Med Commun; 1998 Nov; 19(11):1055-63. PubMed ID: 9861622 [TBL] [Abstract][Full Text] [Related]
15. Concomitant nodal involvement by Langerhans cell histiocytosis and Hodgkin's lymphoma. Geurten C; Thiry A; Jamblin P; Demarche M; Hoyoux C Pediatr Int; 2015 Dec; 57(6):1214-7. PubMed ID: 26556799 [TBL] [Abstract][Full Text] [Related]
16. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment. Chiewvit S; Thephamongkhol K; Ubolnuch K; Pooliam J; Phongsawat N; Chiewvit P J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734 [TBL] [Abstract][Full Text] [Related]
17. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease. Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534 [TBL] [Abstract][Full Text] [Related]
18. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary Langerhans cell histiocytosis and eosinophilic granuloma. Demeter M; Vankan Y; De Somer F; Perdieus D JBR-BTR; 2012; 95(3):177. PubMed ID: 22880529 [No Abstract] [Full Text] [Related]
20. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma. Hoffmann M; Vogelsang H; Kletter K; Zettinig G; Chott A; Raderer M Gut; 2003 Mar; 52(3):347-51. PubMed ID: 12584214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]